Cell & Gene Therapy Center
The Cell & Gene Therapy Center at ATLATL is built to help teams design, develop, and advance cell and gene therapies from concept to preclinical readiness faster.
The platform integrates cell engineering, gene editing, viral vector development, process optimization, and analytical capabilities into a single, on-site execution environment. Scientists work side-by-side with technical experts, enabling real-time iteration, rapid troubleshooting, and efficient generation of proof-of-concept data.
Core Capabilities：
Cell Engineering & Gene Editing
CRISPR-based editing, viral transduction, and custom cell model development for therapeutic design and validation.
Cell Therapy Process Development
Optimization of cell expansion, activation, and differentiation for T cells, stem cells, and other therapeutic cell types.
Gene Delivery & Vector Development
Development and evaluation of viral (lentivirus, AAV) and non-viral delivery systems.
Functional & Potency Assays
Flow cytometry, cytotoxicity assays, and cytokine profiling to evaluate therapeutic activity.
Quality Control & Characterization
Identity, purity, viability, and safety testing to ensure robust and reproducible workflows.
Equipments：
Bio-Rad Gel Doc™ EZ System
Bio-Rad Gene Pulser Xcell
Bio-Rad QX200 AutoDG Droplet Digital PCR System
Bio-Rad T100 Thermal Cycler
Celetrix LE Cell Electroporation System
Leica Mateo TL digital transmitted light inverted microscope
Revvity Cellometer K2 Fluorescent Cell Counter
Miltenyi Biotec gentle MACS™ Octo Dissociator with Heater
Thermo Countess 3 Automated Cell Counter
Thermo NanoDrop™ OneC Spectrophotometer
Thermo SimpliAmp™ Thermal Cycler
R&D Applications：
CAR-T / TCR-T Development
Design, engineering, and validation of immune cell therapies
Gene Editing & Functional Genomics
Knockout/knock-in models and pathway validation
Stem Cell & iPSC Programs
Differentiation, disease modeling, and regenerative applications
Viral Vector Development
Lentivirus and AAV production, purification, and titration
Preclinical Evaluation
In vitro and ex vivo models, including co-culture and organoid systems
Process Scale-Up & Tech Transfer
Transition from research to pilot-scale production
English 
日本語 
简体中文 
Français 
Deutsch